TransMedics (TMDX) Research & Development (2018 - 2025)
Historic Research & Development for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $15.3 million.
- TransMedics' Research & Development rose 696.76% to $15.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.8 million, marking a year-over-year increase of 2895.26%. This contributed to the annual value of $56.0 million for FY2024, which is 5522.95% up from last year.
- Per TransMedics' latest filing, its Research & Development stood at $15.3 million for Q3 2025, which was up 696.76% from $15.9 million recorded in Q2 2025.
- In the past 5 years, TransMedics' Research & Development registered a high of $17.2 million during Q1 2025, and its lowest value of $4.5 million during Q1 2021.
- For the 5-year period, TransMedics' Research & Development averaged around $10.0 million, with its median value being $8.3 million (2023).
- Its Research & Development has fluctuated over the past 5 years, first crashed by 2719.68% in 2021, then skyrocketed by 9383.41% in 2024.
- Quarter analysis of 5 years shows TransMedics' Research & Development stood at $6.3 million in 2021, then fell by 8.84% to $5.8 million in 2022, then skyrocketed by 86.95% to $10.8 million in 2023, then soared by 53.0% to $16.5 million in 2024, then decreased by 7.31% to $15.3 million in 2025.
- Its Research & Development was $15.3 million in Q3 2025, compared to $15.9 million in Q2 2025 and $17.2 million in Q1 2025.